MRK — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates MRK as Bearish with 75% confidence in the Healthcare sector.
AI Analysis Summary
MRK presents significant risks due to extreme debt levels, declining earnings, and overvaluation despite strong cash flow generation.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 25/100
- Bill Ackman (Activist Investing): Grade C — 52/100
- Ray Dalio (Macro/Risk Parity): Grade B — 60/100
Consensus: Bearish
Price Intelligence
- Current price: $111.90
- Price target: $111.76 (-0.1%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: intangible assets
Peer Group Analysis
MRK is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.